RipamontiC., ZeccaE., BrueraE.An update on the clinical use of methadone for cancer pain. Pain1997; 70: 109–115.
2.
GannonC.The use of methadone in the care of the dying. Eur J Palliat Care1997; 4: 152–158.
3.
EddyN.B., HalbachH., BraendenO.J.Synthetic substances with morphine-like effect. Bull World Health Organ1957; 17: 569–863.
4.
DoleV.P., NyswanderM.A medical treatment for diacetylmorphine (heroin) addiction. JAMA1965; 193: 80–84.
5.
BeaverW.T., WallensteinS.L., HoudeR.W., RogersA.A clinical comparison of the analgesic effects of methadone and morphine administered intramuscularly, and orally and parenterally administered methadone. Clin Pharmacol Ther1967; 8: 415–426.
6.
InturrisiC.E., VerebelyK.Disposition of methadone in man after a single oral dose. Clin Pharmacol Ther1972; 13: 923–930.
DoleV.P., KreekM.J.Methadone plasma level: sustained by a reservoir of drug in tissue. Proc Natl Acad Sci1973; 70: 10.
9.
OlsenG.D.Methadone binding to human plasma proteins. Clin Pharmacol Ther1973; 14: 338–343.
10.
PohlandA., BoazH.E., SullivanH.R.Synthesis and identification of metabolites resulting from the biotransformation of d,l-methadone in man and in the rat. J Med Chem1971; 14: 194–197.
11.
VerebelyK., VolavkaJ., MuleS., ResnickR.Methadone in man: pharmacokinetic and excretion studies in acute and chronic treatment. Clin Pharmacol Ther1975; 18: 180–190.
12.
InturrisiC.E., VerebelyK.The levels of methadone in the plasma in methadone maintenance. Clin Pharmacol Ther1972; 13: 633–637.
13.
InturrisiC.E., ColburnW.A., KaikoR.F., HoudeR.W., FoleyK.M.Pharmacokinetics and pharmacodynamics of methadone in patients with chronic pain. Clin Pharmacol Ther1987; 41: 392–401.
14.
SymondsP.Methadone and the elderly. Br Med J1977; 1: 512.
15.
TwycrossR.G.A comparison of diamorphine with cocaine and methadone. Br J Clin Pharmacol1977; 4: 691–693.
16.
EttingerD.S., VitaleP.J., TrumpD.L.Important clinical pharmacological considerations in the use of methadone in cancer patients. Cancer Treat Rep1979; 63: 457–459.
17.
SaweJ., HansenJ., GinmanC., HartvigP., JakobssonP.A., NilssonMlPatient-controlled dose regimen of methadone for chronic cancer pain. Br Med J1981; 282: 771–773.
18.
PaalzowL., NilssonL., StenbergP.Pharmacokinetic basis for optimal methadone treatment of pain in cancer patients. Acta Anaesthesiol Scand1982; 74: 55–58.
19.
PlummerJ.L., GourlayG.K., CherryD.A., CousinsM.J.Estimation of methadone clearance: application in the management of cancer pain. Pain1988; 33: 313–322.
20.
VentafriddaV., RipamontiC., BianchiM., SbanottoA., De ConnoF.A randomized study on oral administration of morphine and methadone in the treatment of cancer pain. J Pain Symptom Manage1986; 1: 203–207.
21.
GalerB.S., CoyleN., PasternakG.W., PortenoyR.K.Individual variability in the response to different opioids: report of five cases. Pain1992; 49: 87–91.
22.
CrewsJ.C., SweeneyN.J., DensonD.D.Clinical efficacy of methadone in patients refractory to other mu-opioid receptor agonist analgesics for management of terminal cancer pain. Cancer1993; 72: 2266–2272.
23.
MorleyJ.S., WattJ.W.G., WellsJ.C., MilesJ.B.Methadone in pain uncontrolled by morphine. Lancet1993; 342: 1243.
24.
LengG., FinneganM.J.Successful use of methadone in nociceptive cancer pain unresponsive to morphine. Palliat Med1994; 8: 153–155.
25.
SjogrenP., JensenN., JensenT.S.Disappearance of morphine-induced hyperalgesia after discontinuing or substituting morphine with other opioid agonists. Pain1994; 59: 313–316.
26.
BrueraE., WatanabeS., FainsingerR.L., SpachynskiK., Suarez-AlmazorM., InturrisiC.Custom-made capsules and suppositories of methadone for patients on high-dose opioids for cancer pain. Pain1995; 62: 141–145.
27.
De StoutzN., BrueraE., Suarez-AlmazorM.Opioid rotation for toxicity reduction in terminal cancer patients. J Pain Symptom Manage1995; 10: 378–384.
28.
ThomasZ., BrueraE.Use of methadone in a highly tolerant patient receiving parenteral hydromorphone. J Pain Symptom Manage1995; 10: 315–317.
29.
ViganoA., FanD., BrueraE.Individualized use of methadone and opioid rotation in the comprehensive management of cancer pain associated with poor prognostic indicators. Pain1996; 67: 115–119.
30.
RimmerT., TrotmanI.Methadone restores opioid sensitivity in cancer pain. Palliat Med1996; 10: 58.
31.
WatanabeS., BelzileM., KuehnN., HansonJ., BrueraE.Capsules and suppositories of methadone for patients on high-dose opioids for cancer pain: clinical and economic considerations. Cancer Treat Rev1996; 22(Suppl. A): 131–136.
32.
ManfrediP.L., BorsookD., ChandlerS.W., PayneR.Intravenous methadone for cancer pain unrelieved by morphine and hydromorphone: clinical observations. Pain1997; 70: 99–101.
33.
FitzgibbonD.R., ReadyL.B.Intravenous high-dose methadone administered by patient-controlled analgesia and continuous infusion for the treatment of cancer pain refractory to high-dose morphine. Pain1997; 73: 259–261.
34.
BrueraE., PereiraJ., WatanabeS., BelzileM., KuehnN., HansonJ.Opioid rotation in patients with cancer pain. Cancer1996; 78: 852–857.
35.
LawlorP.G., TurnerK.S., HansonJ., BrueraE.D.Dose ratio between morphine and methadone in patients with cancer pain. Cancer1998; 82: 1167–1173.
36.
RipamontiC., GraffL., BrunelliC., PolastriD., StavrakisA., De ConnoF.Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose?J Clin Oncol1998; 16: 3216–3221.
37.
De ConnoF., GraffL., BrunelliC., ZeccaE., VentafriddaV., RipamontiC.Clinical experience with oral methadone administration in the treatment of pain in 196 advanced cancer patients. J Clin Oncol1996; 14: 2836–2842.
38.
MercadanteS., CasuccioA., AgnelloA., SerrettaR., CalderoneL., BarresiL.Morphine versus methadone in the pain treatment of advanced cancer patients followed up at home. J Clin Oncol1998; 16: 3656–3661.
39.
EbertB., AndersonS., Krogsgaard-LarsenP.Ketobemidone, methadone and pethidine are non-competitive N-methyl-D-aspartate (NMDA) antagonists in the rat cortex and spinal cord. Neurosci Lett1995; 187: 165–168.
40.
GormanA.L., ElliottK.J., InturrisiC.E.The d- and l-isomers of methadone bind to the non-competitive site on the N-methyl-D-aspartate (NMDA) receptor in rat forebrain and spinal cord. Neurosci Lett1997; 223: 5–8.
MakinM.K., O'DonnellV., SkinnerJ.M., EllershawJ.E.Methadone in the management of cancer related neuropathic pain: report of five cases. Pain Clin1998; 10: 275–279.
